内容へ

血液内科

再生不良性貧血

Eltrombopag added to immunosuppression in severe aplastic anemia. (新しいタブで開く)

Peffault de Latour R, Kulasekararaj A, Iacobelli S, Terwel SR, Cook R, Griffin M, Halkes CJM, Recher C, Barraco F, Forcade E, Vallejo JC, Drexler B, Mear JB, Smith AE, Angelucci E, Raymakers RAP, de Groot MR, Daguindau E, Nur E, Barcellini W, Russell NH, Terriou L, Iori AP, La Rocca U, Sureda A, Sánchez-Ortega I, Xicoy B, Jarque I, Cavenagh J, Sicre de Fontbrune F, Marotta S, Munir T, Tjon JML, Tavitian S, Praire A, Clement L, Rabian F, Marano L, Hill A, Palmisani E, Muus P, Cacace F, Frieri C, van Lint MT, Passweg JR, Marsh JCW, Socié G, Mufti GJ, Dufour C, Risitano AM; Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation

出典‎: N Engl J Med 2022;386(1):11-23.

インデックス‎: PubMed 34986284

DOI‎: 10.1056/NEJMoa2109965

https://pubmed.ncbi.nlm.nih.gov/34986284/ (新しいタブで開く)

Eltrombopag added to standard immunosuppression for aplastic anemia. (新しいタブで開く)

Townsley DM, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O, Weinstein B, Valdez J, Lotter J, Feng X, Desierto M, Leuva H, Bevans M, Wu C, Larochelle A, Calvo KR, Dunbar CE, Young NS

出典‎: N Engl J Med 2017;376(16):1540-50.

インデックス‎: PubMed 28423296

DOI‎: 10.1056/NEJMoa1613878

https://www.ncbi.nlm.nih.gov/pubmed/28423296 (新しいタブで開く)